欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/1181/004
药品名称Olmesartan + Hidroclorotiazida Aurobindo
活性成分
    • hydrobentizide 25.0 mg
    • olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人Aurobindo Pharma (Portugal), Unipessoal Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Malta (MT)
      Olmesartan/Hydrochlorthiazide 40mg/25mg film-coated tablets
    • Germany (DE)
      Olmesartan/Hydrochlorothiazid Aurobindo 40 mg/25 mg Filmtabletten
    • Belgium (BE)
    • Luxembourg (LU)
    • Netherlands (NL)
    • Italy (IT)
许可日期2014/08/20
最近更新日期2024/04/18
药物ATC编码
    • C09DA08 olmesartan medoxomil and diuretics
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase